Considering LCETRL3 and LCETRL4 located at the GWAS-identified 4q12 locus significantly associated with PFS of the EGFR-TKIs-treated NSCLC patients, we further evaluated how these lncRNAs impact the gefitinib sensitivity of NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.